T2 Biosystems, Inc.
TTOO
Revenue
1.95M
▼-109.00k▼-5.29%
3 Months ChangeAssets
21.72M
▼-3.03M▼-12.26%
3 Months ChangeLiabilities
27.62M
▼-34.91M▼-55.83%
3 Months ChangeFree Cash Flow
-13.06M
▲1.41M▲9.74%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-16
Form 8-K
ID: 0001193125-24-238172
2024-10-07
Form 8-K
ID: 0001193125-24-233395
2024-09-20
Form 8-K
ID: 0001193125-24-222496
2024-09-16
Form 8-K
ID: 0001193125-24-219279
2024-09-09
Form 8-K
ID: 0001193125-24-215565
2024-08-08
Form 10-Q
ID: 0000950170-24-094135
2024-07-29
Form 8-K
ID: 0001193125-24-187710
2024-07-19
Form 8-K
ID: 0001193125-24-181657
2024-05-22
Form 8-K
ID: 0001193125-24-145025
2024-05-20
Form 8-K
ID: 0001193125-24-142204